Enterobiome Inc.

Enterobiome specializes in next-generation probiotics, with a strong focus on Akkermansia muciniphila and Faecalibacterium prausnitzii. Scientific research has demonstrated that these bacterial species, key members of the human gut microbiota, are causally linked to various incurable diseases. Globally, A. muciniphila is gaining recognition as a next-generation probiotic, with commercial products increasingly entering the market.

Enterobiome has achieved GRAS (Generally Recognized As Safe) status, secured the first regulatory approval in South Korea, and marked the first case with a functional claim for respiratory health. Building on this foundation, Enterobiome launched Flouren, its first commercialized product, designed to harness Akkermansia’s proven benefits through cutting-edge microbiome science.

With Flouren, Enterobiome is actively seeking retail partners as well as OEM/ODM collaborations to expand global reach. Our mission is to combine rigorous clinical validation with sustainable innovation, creating products that promote healthier living and reflect our commitment to both people and the planet.

FLOUREN was founded to harness cutting-edge microbiome science, focusing on Akkermansia's proven benefits. With a strong scientific foundation and rigorous clinical validation, we create innovative, sustainable products that promote healthier living and reflect our commitment to people and the planet.